Funded by the NIH HEAL Initiative®
This study will develop and test a culturally-centered program to support the integration of medications (BUP, XR-naltrexone) to treat OUD among AI/AN in primary care and addiction treatment clinics.
Principal Investigator(s)
Kamilla Venner, Ph.D.
Logan Hall 128, CASAA 249
Albuquerque, NM 87131
United States
Aimee Campbell, Ph.D., M.S.W.
1051 Riverside Drive, Unit 120
New York, NY 10032
United States